LIMS Provider LabLynx Sues Accelrys for Trademark Counterfeiting, Infringement | GenomeWeb

NEW YORK (GenomeWeb News) — Laboratory management information system provider LabLynx has sued Accelrys for trademark counterfeiting, trademark infringement, and domain name cyberpiracy, among other things, according to recently filed court documents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.